Model-Based, Goal-Oriented, Individualised Drug Therapy
暂无分享,去创建一个
Alan Schumitzky | Mark Milman | Xin Wang | Pascal Maire | A. Schumitzky | M. Milman | R. Jelliffe | D. Bayard | X. Barbaut | P. Maire | Roger W. Jelliffe | David Bayard | Michael Van Guilder | Feng Jiang | Xavier Barbaut | M. Guilder | Xin Wang | F. Jiang | Roger W. Jelliffe | Michael Guilder
[1] L B Sheiner,et al. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. , 1982, Journal of pharmaceutical sciences.
[2] B. Lindsay. The Geometry of Mixture Likelihoods: A General Theory , 1983 .
[3] R W Jelliffe,et al. Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples. , 1994, International journal of bio-medical computing.
[4] A. Schumitzky. Nonparametric EM Algorithms for estimating prior distributions , 1991 .
[5] E. Vonesh,et al. Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.
[6] A. Mallet,et al. Preliminary results of three methods for population pharmacokinetic analysis (NONMEM, NPML, NPEM) of amikacin in geriatric and general medicine patients. , 1994, International journal of bio-medical computing.
[7] Adrian F. M. Smith,et al. Bayesian Analysis of Linear and Non‐Linear Population Models by Using the Gibbs Sampler , 1994 .
[8] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[9] R. Kalaba,et al. Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens. , 1972, Annals of internal medicine.
[10] L B Sheiner,et al. Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.
[11] J. L. Steimer,et al. Variability in drug therapy : description, estimation, and control : a Sandoz workshop , 1985 .
[12] R. Jelliffe,et al. Population Pharmacokinetic Models , 1993 .
[13] Dimitri P. Bertsekas,et al. Dynamic Programming: Deterministic and Stochastic Models , 1987 .
[14] F. Follath,et al. Rapid Prediction of Individual Dosage Requirements for Lignocaine , 1984, Clinical pharmacokinetics.
[15] C. Destache,et al. Impact of a Clinical Pharmacokinetic Service on Patients Treated with Aminoglycosides: A Cost‐Benefit Analysis , 1990, Therapeutic drug monitoring.
[16] C. Destache,et al. Does Accepting Pharmacokinetic Recommendations Impact Hospitalization? A Cost‐Benefit Analysis , 1990, Therapeutic drug monitoring.
[17] M. Degroot,et al. Probability and Statistics , 2021, Examining an Operational Approach to Teaching Probability.
[18] Leon Aarons. The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.
[19] R W Jelliffe,et al. Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapy. , 1994, Proceedings. Symposium on Computer Applications in Medical Care.
[20] Roger W. Jelliffe,et al. Individualizing Drug Dosage Regimens: Roles of Population Pharmacokinetic and Dynamic Models, Bayesian Fitting, and Adaptive Control , 1993, Therapeutic drug monitoring.
[21] L B Sheiner,et al. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. , 1984, Drug metabolism reviews.
[22] A. Mallet. A maximum likelihood estimation method for random coefficient regression models , 1986 .
[23] D. Lainiotis,et al. Partitioning: A unifying framework for adaptive systems, I: Estimation , 1976, Proceedings of the IEEE.
[24] R E Notari,et al. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. , 1973, The Journal of clinical pharmacology and new drugs.
[25] S L Beal,et al. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. , 1984, Drug metabolism reviews.
[26] Marie Davidian,et al. The Nonlinear Mixed Effects Model with a Smooth Random Effects Density , 1993 .
[27] D. Zaske,et al. Increased burn patient survival with individualized dosages of gentamicin. , 1982, Surgery.
[28] R Jouvent,et al. Nonparametric Estimation of Population Characteristics of the Kinetics of Lithium from Observational and Experimental Data: Individualization of Chronic Dosing Regimen Using a New Bayesian Approach , 1994, Therapeutic drug monitoring.
[29] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[30] R. Jelliffe,et al. Individualising Gentamicin Dosage Regimens , 1991, Clinical pharmacokinetics.
[31] R W Jelliffe,et al. Clinical studies with computer-assisted initial lidocaine therapy. , 1984, Archives of internal medicine.
[32] A Schumitzky,et al. Design of dosage regimens: a multiple model stochastic control approach. , 1994, International journal of bio-medical computing.
[33] R W Jelliffe,et al. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens , 1990, Antimicrobial Agents and Chemotherapy.
[34] L. Bertilsson,et al. Geographical/Interracial Differences in Polymorphic Drug Oxidation , 1995, Clinical pharmacokinetics.